Resources

Patients with Type 2 diabetes now have a new treatment option: saxagliptin, a dipeptidyl peptidase-4 inhibitor that stimulates the pancreas to create more insulin after meals.

Several risk factors may help identify factors linked to poor outcomes for bariatric surgery, according to the results of a study. 

Medingo US, Inc., announced that it will introduce its miniature, tube-free insulin delivery system, the Solo MicroPump, at the American Association of Diabetes Educators Meeting in Atlanta, GA, August 5-8, 2009, Booth 730 . The company received its FDA clearance letter (K090245) on July 28, 2009.

Elevated triglyceride levels are an independent predictor of myelinated fiber density (MFD) loss in patients with mild to moderate diabetic neuropathy, according to a report.

Pediatric researchers have found that a gene previously shown to be involved in the development of Type 2 diabetes also predisposes children to having a lower birth weight.  

When it comes to nutrition, there’s no difference whether patients consume organic or conventionally produced foods, researchers say.

The Juvenile Diabetes Research Foundation has announced that it has launched an on-line service for people with Type 1 diabetes and their families to easily find information about clinical trials for drugs, treatments, and therapeutics for diabetes and its complications. 

Whole flaxseed and flaxseed lignans significantly reduce circulating total cholesterol and low-density lipoprotein (LDL) cholesterol levels, showing their greatest effect in postmenopausal women and individuals with high initial cholesterol concentrations, according to the results of a published study. 

Researchers report that over-the-counter allergy and asthma drugs helped obese and diabetic mice lose weight and control their blood sugar. 

  Research suggests promising chemopreventive role for metformin by reducing the risk of pancreatic cancer by 62 percent.